Authors:
DRESSELHAUS TR
LUCK J
WRIGHT BC
SPRAGG RG
LEE ML
BOZZETTE SA
Citation: Tr. Dresselhaus et al., ANALYZING THE TIME AND VALUE OF HOUSESTAFF INPATIENT WORK, Journal of general internal medicine, 13(8), 1998, pp. 534-540
Citation: Ds. Zingmond et Sa. Bozzette, MANAGEMENT OF MYCOBACTERIUM-AVIUM COMPLEX IN AIDS - USING MONTE-CARLOMETHODS TO ASSESS STRATEGIES FOR DISEASE PREVENTION AND TREATMENT, Medical decision making, 18(4), 1998, pp. 463-463
Authors:
HAVLIR DV
DUBE MP
SATTLER FR
FORTHAL DN
KEMPER CA
DUNNE MW
PARENTI DM
LAVELLE JP
WHITE AC
WITT MD
BOZZETTE SA
MCCUTCHAN JA
Citation: Dv. Havlir et al., PROPHYLAXIS AGAINST DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX WITH WEEKLY AZITHROMYCIN, DAILY RIFABUTIN, OR BOTH (REPRINTED FROM THE NEW-ENGLAND JOURNAL OF MEDICINE, VOL 335, PG 392-398, 1996), Formulary, 32, 1997, pp. 20-28
Authors:
CATANZARO A
WOODS GL
SIERRA MF
CANTOR SB
DELLALATTA P
EISENACH KD
HANSON SL
METCHOCK B
SALFINGER M
YAJKO DM
GORDIN F
SCHLUGER NW
BATES JH
BREWER TF
CHIN D
COHN DL
GANIATS TG
GOLDBERGER MJ
MATTHEWS WC
ROSE DN
FUJIWARA PI
SBABARO J
BOZZETTE SA
CHAISSON RE
DAVIDSON DL
GEITER LJ
JORDAN TJ
MOSER KS
REICHMAN LB
Citation: A. Catanzaro et al., RAPID DIAGNOSTIC-TESTS FOR TUBERCULOSIS - WHAT IS THE APPROPRIATE USE, American journal of respiratory and critical care medicine, 155(5), 1997, pp. 1804-1814
Authors:
WU AW
HAYS RD
KELLY S
MALITZ F
BOZZETTE SA
Citation: Aw. Wu et al., APPLICATIONS OF THE MEDICAL OUTCOMES STUDY HEALTH-RELATED QUALITY-OF-LIFE MEASURES IN HIV AIDS/, Quality of life research, 6(6), 1997, pp. 531-554
Authors:
DUBE MP
SATTLER FR
TORRIANI FJ
SEE D
HAVLIR DV
KEMPER CA
DEZFULI MG
BOZZETTE SA
BARTOK AE
LEEDOM JM
TILLES JG
MCCUTCHAN JA
Citation: Mp. Dube et al., RANDOMIZED EVALUATION OF ETHAMBUTOL FOR PREVENTION OF RELAPSE AND DRUG-RESISTANCE DURING TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX BACTEREMIA WITH CLARITHROMYCIN-BASED COMBINATION THERAPY, The Journal of infectious diseases, 176(5), 1997, pp. 1225-1232
Authors:
SHINKAI M
BOZZETTE SA
POWDERLY W
FRAME P
SPECTOR SA
Citation: M. Shinkai et al., UTILITY OF URINE AND LEUKOCYTE-CULTURES AND PLASMA DNA-POLYMERASE CHAIN-REACTION FOR IDENTIFICATION OF AIDS PATIENTS AT RISK FOR DEVELOPINGHUMAN CYTOMEGALOVIRUS DISEASE, The Journal of infectious diseases, 175(2), 1997, pp. 302-308
Authors:
HAVLIR DV
DUBE MP
SATTLER FR
FORTHAL DN
KEMPER CA
DUNNE MW
PARENTI DM
LAVELLE JP
WHITE AC
WITT MD
BOZZETTE SA
MCCUTCHAN JA
Citation: Dv. Havlir et al., PROPHYLAXIS AGAINST DISSEMINATED MYCOBACTERIUM-AVIUM COMPLEX WITH WEEKLY AZITHROMYCIN, DAILY RIFABUTIN, OR BOTH, The New England journal of medicine, 335(6), 1996, pp. 392-398
Authors:
SCHAMBELAN M
MULLIGAN K
GRUNFELD C
DAAR ES
LAMARCA A
KOTLER DP
WANG J
BOZZETTE SA
BREITMAYER JB
HURLEY A
JAVALY K
PITT J
PANG M
HEALD AE
SHIPP KW
PEARCE D
SOVA K
PATE P
BOSWELL SL
FLYNN T
POLSKY B
HAVERSTICK L
ROTHKOPF MM
BLIFFEN DL
ROSENFELD R
PIERSON RN
WINSON G
TAI V
BENNISON WM
KENNEDY SM
NEU TK
ROBINSON CE
SCHWALBERT RJ
LAMARCA D
KURITZKES DR
RAY MG
MELLORS JW
BALSER BE
BALSER JP
Citation: M. Schambelan et al., RECOMBINANT HUMAN GROWTH-HORMONE IN PATIENTS WITH HIV-ASSOCIATED WASTING - A RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 125(11), 1996, pp. 873
Citation: Sa. Bozzette et Sc. Morton, RECONSIDERING THE USE OF ADJUNCTIVE CORTICOSTEROIDS IN PNEUMOCYSTIS PNEUMONIA, Journal of acquired immune deficiency syndromes and human retrovirology, 8(4), 1995, pp. 345-347
Authors:
BOZZETTE SA
HAYS RD
BERRY SH
KANOUSE DE
WU AW
Citation: Sa. Bozzette et al., DERIVATION AND PROPERTIES OF A BRIEF HEALTH-STATUS ASSESSMENT INSTRUMENT FOR USE IN HIV DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 8(3), 1995, pp. 253-265
Citation: Sa. Bozzette et S. Asch, DEVELOPING QUALITY REVIEW CRITERIA FROM STANDARDS OF CARE FOR HIV DISEASE - A FRAMEWORK, Journal of acquired immune deficiency syndromes and human retrovirology, 8, 1995, pp. 45-52
Citation: Sa. Bozzette, SPECIFIC CONSIDERATIONS FOR COST-EFFECTIVENESS STUDIES IN AIDS, Journal of acquired immune deficiency syndromes and human retrovirology, 10, 1995, pp. 23-27
Citation: Pm. Girard et Sa. Bozzette, STRATEGIES FOR PROPHYLAXIS OF PNEUMOCYSTIS-CARINII PNEUMONIA, Bailliere's clinical infectious diseases, 2(3), 1995, pp. 551-571
Citation: Sa. Bozzette et al., HEALTH-STATUS AND FUNCTION WITH ZIDOVUDINE OR ZALCITABINE AS INITIAL THERAPY FOR AIDS - A RANDOMIZED CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 273(4), 1995, pp. 295-301
Authors:
BOZZETTE SA
FINKELSTEIN DM
SPECTOR SA
FRAME P
POWDERLY WG
HE WL
PHILLIPS L
CRAVEN D
VANDERHORST C
FEINBERG J
Citation: Sa. Bozzette et al., A RANDOMIZED TRIAL OF 3 ANTIPNEUMOCYSTIS AGENTS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 332(11), 1995, pp. 693-699
Authors:
POWDERLY WG
FINKELSTEIN DM
FEINBERG J
FRAME P
HE WL
VANDERHORST C
KOLETAR SL
EYSTER ME
CAREY J
WASKIN H
HOOTON TM
HYSLOP N
SPECTOR SA
BOZZETTE SA
Citation: Wg. Powderly et al., A RANDOMIZED TRIAL COMPARING FLUCONAZOLE WITH CLOTRIMAZOLE TROCHES FOR THE PREVENTION OF FUNGAL-INFECTIONS IN PATIENTS WITH ADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, The New England journal of medicine, 332(11), 1995, pp. 700-705
Authors:
CUNNINGHAM WE
BOZZETTE SA
HAYS RD
KANOUSE DE
SHAPIRO MF
Citation: We. Cunningham et al., COMPARISON OF HEALTH-RELATED QUALITY-OF-LIFE IN CLINICAL-TRIAL AND NONCLINICAL TRIAL HUMAN IMMUNODEFICIENCY VIRUS-INFECTED COHORTS, Medical care, 33(4), 1995, pp. 15-25
Authors:
BOZZETTE SA
FORTHAL D
SATTLER FR
KEMPER C
RICHMAN DD
TILLES JG
LEEDOM J
MCCUTCHAN JA
Citation: Sa. Bozzette et al., THE TOLERANCE FOR ZIDOVUDINE PLUS THRICE WEEKLY OR DAILY TRIMETHOPRIM-SULFAMETHOXAZOLE WITH AND WITHOUT LEUCOVORIN FOR PRIMARY PROPHYLAXIS IN ADVANCED HIV DISEASE, The American journal of medicine, 98(2), 1995, pp. 177-182
Authors:
LARSEN RA
BOZZETTE SA
JONES BE
HAGHIGHAT D
LEAL MA
FORTHAL D
BAUER M
TILLES JG
MCCUTCHAN JA
LEEDOM JM
Citation: Ra. Larsen et al., FLUCONAZOLE COMBINED WITH FLUCYTOSINE FOR TREATMENT OF CRYPTOCOCCAL MENINGITIS IN PATIENTS WITH AIDS, Clinical infectious diseases, 19(4), 1994, pp. 741-745
Citation: Sa. Bozzette et al., A COST-ANALYSIS OF APPROVED ANTIRETROVIRAL STRATEGIES IN PERSONS WITHADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE AND ZIDOVUDINE INTOLERANCE, Journal of acquired immune deficiency syndromes, 7(4), 1994, pp. 355-362
Citation: Sa. Bozzette et al., A COST-ANALYSIS OF APPROVED ANTIRETROVIRAL STRATEGIES IN PERSONS WITHADVANCED HUMAN-IMMUNODEFICIENCY-VIRUS DISEASE AND ZIDOVUDINE INTOLERANCE (VOL 7, PG 355, 1994), Journal of acquired immune deficiency syndromes, 7(11), 1994, pp. 1212-1212
Citation: Sa. Bozzette et al., ANALYTIC DIFFICULTIES IN APPLYING QUALITY-OF-LIFE OUTCOMES TO CLINICAL-TRIALS OF THERAPY FOR HIV DISEASE, Psychology & health, 9(1-2), 1994, pp. 143-156